Bio-Matrix Scientific Group Inc. To Unveil Stem Cell Extraction Devices at the American Association of Tissue Banks
Posted on: Wednesday, 6 September 2006, 09:01 CDT
Bio-Matrix Scientific Group Inc. (OTCBB:BMSN), a biotechnology company focused on stem cell cryogenics and disposable stem cell / tissue transfer instruments, announced today that it will unveil its new stem cell extraction kits at the American Association of Tissue Banks.
Brian Pockett, Managing Director and COO, stated, "We feel that this is an excellent opportunity to introduce our stem cell extraction kits to physicians and specialists in the tissue banking industry."
The American Association of Tissue Banks 30th Annual Meeting in San Diego, CA, September 9-12, 2006, is designed for physicians who are medical directors or pathologists; those physician specialists (e.g., orthopedic surgeons, burn surgeons) who rely on the use of tissue in patient care and treatment; tissue bank specialists; quality assurance staff; and all others involved in tissue banking.
About Bio-Matrix Scientific Group Inc.
Bio-Matrix Scientific Group Inc. (www.BMSNonline.com), is a biotech research and development Company that commercializes medical devices and monitoring systems for the growing, worldwide stem cell research market.
The Company aligns itself with strategic partners that offer key technologies in biomedical device development, tissue engineering, cell culturing, genome therapy and drug delivery systems to become a leading source for stem cell research technology and innovation and is building a state-of-the-art facility in San Diego, California, to cater to the growing stem cell research segment of the $75 billion biotechnology and medical device industry.
DISCLAIMER: This news release may contain forward-looking statements. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.
Source: Business Wire
Related Articles
- Sangamo BioSciences Announces Research Collaboration With UCLA in Human Stem Cells Selected to Receive Clinical Research Award
- Labeling Comprehension Studies Found to Reduce Medical Product Risk and Accelerate Regulatory Approval
- Leadis Technology Announces Major Step Forward in Active Matrix OLED Display (AMOLED) Strategy
- Stem Cells May Look Malignant, Not Act It
- Bio-Matrix Scientific CEO Highlights Plans for First Commercial Adult Stem Cell Bank Derived From Fat and Medical Devices Aimed at Plastic Surgeons and Liposuction Patients
- National Stem Cell Announces Publication of Sponsored Research Findings for Type I Diabetes
- HCA Names Kevin Hicks Research Medical Center CEO
- Cell Therapeutics Issues Statement on Study in Women With Lung Cancer
- Affymetrix Microarrays Uncover Genetic Mutations in Embryonic Stem Cells Approved for Federally-Funded Research; Scientists Report That Majority of Cells Develop Mutations Over Time
- Chemicon International, Inc. Enters into a License to Commercialize Research Products Utilizing Human Embryonic Stem Cell Technology From Wisconsin Alumni Research Foundation (WARF)
 |
 |
User Comments (0)
RSS Feeds